This product consists of a CRISPR/Cas9-edited polyclonal knockout cell population in which the AGFG1 gene has been disrupted in the HT29 human colorectal adenocarcinoma cell line. The polyclonal format provides a heterogeneous pool of cells harboring targeted gene disruption, enabling loss-of-function studies without the selection of a single clonal isolate. The heterogeneous nature of the population can reveal dominant phenotypic effects while capturing the diversity of genetic edits introduced by CRISPR/Cas9-mediated cleavage. This model is suitable for investigating AGFG1-dependent cellular processes in a colorectal cancer background, offering a robust tool for applications ranging from basic endocytosis research to drug response profiling.
The host HT29 cell line is a well-characterized epithelial cell model derived from a primary human colorectal adenocarcinoma. HT29 cells are widely employed in studies of intestinal barrier function, drug absorption, and colorectal cancer biology due to their capacity to form polarized monolayers and differentiate under appropriate conditions. Their epithelial origin and tumorigenic properties make them particularly relevant for investigating the molecular mechanisms underlying colorectal adenocarcinoma progression, metastasis, and therapeutic resistance. The retention of key signaling pathways, including EGFR signaling, further enhances their utility for dissecting growth factor receptor trafficking and downstream effector functions in a cancer-relevant context.
AGFG1 encodes an ARF GTPase-activating protein that functions as a critical regulator of clathrin-mediated endocytosis and endosomal trafficking. AGFG1 acts downstream of ARF6 and is activated by EGF stimulation, facilitating the recycling of internalized EGFR back to the plasma membrane. It interacts directly with clathrin heavy chain, the AP-2 adaptor complex, and the HIV-1 Rev protein, linking vesicle coat assembly to nuclear export processes. Through its GAP activity toward ARF1 and ARF6, AGFG1 coordinates the formation and disassembly of clathrin coats on endocytic vesicles, thereby modulating the trafficking of cargoes such as EGFR. In the context of HIV-1 infection, AGFG1 bridges viral Rev with the CRM1 nuclear export receptor and NUP98 to promote the cytoplasmic export of unspliced viral mRNA. Representative pathway components that operate alongside AGFG1 include EEA1, Rab5, and components of the AP-2 complex, all of which contribute to early endosome dynamics and cargo sorting.
In HT29 colorectal adenocarcinoma cells, AGFG1 knockout is expected to impair EGFR recycling, leading to altered EGFR signaling duration and intensity, which may influence cell proliferation, migration, and drug sensitivity. The disruption of AGFG1-mediated endosomal trafficking could also affect the cellular distribution of adhesion molecules and matrix-remodeling enzymes, thereby impacting metastatic behavior. Moreover, because HT29 cells are susceptible to HIV-1 pseudotype transduction, this knockout model provides a relevant platform for examining the contribution of AGFG1 to HIV-1 Rev-dependent RNA export in a cancer cell environment. The polyclonal nature of the knockout population allows for the observation of functional consequences arising from a range of gene-disruption events, offering a broad view of AGFG1’s role in colorectal cancer biology.
Key research applications include quantitative analysis of EGFR internalization and recycling via immunofluorescence or transferrin uptake assays, assessment of cell migration and invasion using Boyden chamber or wound-healing assays, and evaluation of drug response profiles through viability assays. Co-immunoprecipitation experiments can be employed to probe interactions between AGFG1, clathrin, and AP-2, while RT-qPCR and Western blotting enable verification of target gene disruption and downstream effector changes. Researchers studying HIV-1 host factors may utilize these cells to measure viral mRNA export efficiency using reporter constructs. This polyclonal knockout model thus supports a broad range of mechanistic and translational studies in endocytic trafficking, signal transduction, and host-pathogen interactions. For further technical information, please contact Ascent Research.
